2020 Speakers

Photo of Dr. Julie Johnson Julie A. Johnson, Pharm.D.

Dean and Distinguished Professor, College of Pharmacy
Director, UF Health Personalized Medicine Program
Member of the National Academy of Medicine
Department of Pharmacotherapy and Translational Research
University of Florida

Focus areas: cardiovascular pharmacogenomics, clinical implementation, translational research


Photo portrait of Dr. Michael Pacanowski Michael A. Pacanowski, M.P.H., Pharm.D.

Associate Director for Genomics and Targeted Therapy
Food and Drug Administration

Focus areas: Pharmacogenomics, personalized medicine, clinical pharmacology, rare diseases


Larisa Cavallari, pharm.D.,Larisa Cavallari, Pharm.D.

Associate Professor of Pharmacotherapy and Translational Research
Director, Center for Pharmacogenomics
University of Florida

Focus areas: cardiovascular pharmacology, pharmacogenomics, and translational research


Jordan BayesJordan Baye, Pharm.D., M.A.

Assistant Professor
Sanford Health, South Dakota State University

Focus areas: Pharmacogenomics, Ambulatory Care,  Bioethics/Medical Ethics


Roseann Gammal Roseann Gammal, Pharm.D.

Assistant Professor of Pharmacy Practice,
Massachusetts College of Pharmacy and Health Sciences (MCPHS)

Focus areas: pharmacogenomics and pediatrics


Emily CicaliEmily J. Cicali, Pharm.D.

Clinical Assistant Professor
University of Florida

Focus areas:clinical implementation of pharmacogenomics as well as further understanding the role of phenoconversion for optimal medication safety.


Max Smith D. Maxwell Smith III, Pharm.D., BCPs

Clinical Pharmacogenomics Specialist
MedStar Health
Washington, DC

Focus areas: pharmacogenetics, inter‐individual variability in response to medication using pharmacogenetic data to guide patient care has the potential to reduce this variability and improve patient outcomes


Kevin HicksJ. Kevin Hicks, Pharm.D., Ph.D.

Personalized Medicine Specialist
Department of Individualized Cancer Management
Moffitt Cancer Center

Focus areas: Leveraging the electronic health record to integrate pharmacogenomics into routine patient care.


Kelly CaudleKelly E. Caudle, Pharm.D., Ph.D., BCPs

Clinical Pharmacogenetics Implementation Consortium (CPIC) Director
St. Jude Children’s Research Institute

Focus areas: standardization of pharmacogenetic test results such as the CPIC term and CYP2D6 genotype to phenotype standardization projects


Peter OdonnellPeter O’Donnell, M.D.

Associate Professor of Medicine
Department of Medicine
University of Chicago

Focus areas: Treatment of patients with genitourinary malignancies (bladder, prostate, kidney and testicular cancers).


James CrawfordJames Crawford, M.D., Ph.D.

Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Focus areas: Advancement of the role of pathology and the clinical laboratory in the effective delivery of healthcare in this era of accountable care, including the important concepts of patient-centered care and coordinated care.

Effective utilization and interpretation of laboratory testing, the use of laboratory data to manage patient populations, and determining the efficacy of the clinical management of patients as driven by critical laboratory values.


April SchultzApril Schultz, Pharm.D., R.Ph.

Clinical Pharmacists
Manager – Pharmacogenetics at Sanford Imagenetics


David Nelson PortraitDavid R. Nelson, M.D.

Senior Vice President for Health Affairs and President of UF Health
Director, UF Clinical and Translational Science Institute
University of Florida College of Medicine

Focus areas: translational research, hepatology, viral hepatitis, liver cancer


Eimear KennyEimar E. Kenny, Ph.D.

Associate Professor, Medicine, General Internal Medicine
Associate Professor, Genetics and Genomic Sciences

Focus areas: Computational genomics and medicine, Bringing state-of-the-art genomic technology and data science to improve clinical care, particularly in diverse and medically underserved populations


Kurt Christensen Kurt D. Christensen, Ph.D.

Instructor Division of Genetics, Department of Medicine
Brigham and Women’s Hospital, Harvard Medical School

Focus areas: psychosocial aspects of genetic risk assessments


Stephen Rich Stephen Rich, Ph.D.

Professor
Director, Center for Public Health Genomics
University of Virginia Health System

Focus areas: Genetic basis of common human disease, including type 1 diabetes, diabetic complications, ischemic stroke, and atherosclerosis


Susan LamersSusan Lamers, M.S.

Scientific Director, BioInfoExperts

Focus areas: analysis of HIV-1 evolution within human populations and within individuals during disease pathogenesis and transmission
Development of evolutionary computation (machine-learning) to combine genetic sequence data with features associated with HIV-1 disease trajectories to determine complex predictors of disease.


Chad NeilsenChad Neilson, M.P.H.

Director of Infection Prevention and Control, UF Health Jacksonville
Courtesy Assistant Professor, College of Medicine- Jacksonville

Focus areas: infection prevention, epidemiology, policy development, risk management, performance improvement, healthcare quality, research designs, emergency management, military science, hospital administration


James HoffmanJames M. Hoffman, Pharm.D., M.S.

Associate Member, St. Jude Faculty
Chief Patient Safety Officer
St. Jude Children’s Research Hospital

Focus areas: Medication safety and outcomes, Patient safety event detection and reporting systems, Patient safety culture and just culture, Clinical decision support in the electronic medical record


Kathy Tzeng Kathy Tzeng, Ph.D.

Senior Distinguished Engineer and Research Fellow
UnitedHealth Group R&D

Focus areas: Leveraging genomics to improve the overall healthcare with near-term focus on pharmacogenomics and rare disease.


Sonja Rassmussen Profile PictureSonja A. Rasmussen, M.D., M.S.

Professor, Pediatrics and Epidemiology
Colleges of Medicine and Public Health and Health Professions
University of Florida

Focus areas: Using genomics to improve the health of children, Risk factors for birth defects, morbidity and mortality of genetic conditions and birth defects, and the effects of infections and medications during pregnancy


Matthew FarrerMatthew Farrer, Ph.D.

Professor of Neurology
Director of the Clinical Genomics Program, UF Clinical and Translational Science Institute
University of Florida  

Focus areas: genetics of Parkinson’s disease


Howard McleodHoward McLeod, Pharm.D.

Chair, Department of Individualized Cancer Management
Medical Director, DeBartolo Family Personalized Medicine Institute
Professor, University of South Florida Morsani College of Medicine

Focus areas: cancer epidemiology and genomics, pharmacogenomics, clinical pharmacology


Alexander ParkerAlexander S. Parker, Ph.D., M.S

Associate Director, Center for Individualized Medicine
Professor of Epidemiology and Urology
Mayo Clinic

Focus areas: molecular epidemiology of kidney cancer, public health


Sanjay BagariaSanjay P. Bagaria, M.D.

Mayo Clinic Jacksonville

Focus areas: Sarcoma, Hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies, Melanoma, and Breast cancer


Jeanette McCarthyJeanette McCarthy, M.P.H., Ph.D.

Founder, Precision Medicine Advisors

Focus areas: genetic underpinnings of complex diseases, both infectious and chronic


Barbara Conley Barbara Conley, M.D.

Associate Director of the Cancer Diagnosis Program (CDP)
Division of Cancer Treatment and Diagnosis
National Cancer Institute

Focus areas: diagnostic markers, drug development, and cancers of the aerodigestive tract


Christopher Cogle PortraitChristopher R. Cogle, M.D.

Professor, Hematology and Oncology
University of Florida College of Medicine
Scholar in Clinical Research, Leukemia & Lymphoma Society

Focus areas: Myelodysplastic Syndromes, Acute Myeloid Leukemia, Blood & Marrow Transplant, Stem Cell Biology


Mark Dunnenberger Profile PictureMark Dunnenberger, Pharm.D., BCPs

Director of Pharmacogenomics, Center for Personalized Medicine
NorthShore University Health System Center, Chicago, IL

Focus areas: Translating pharmacogenomics into clinical practice, developing information technology solutions for delivering genetic information to both clinicians and patients in a practical manner, and evaluating methods for educating healthcare professionals about pharmacogenetics